Back to Search Start Over

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.

Authors :
Thiagarajan, Divya
Oparina, Nina
Lundström, Susanna
Zubarev, Roman
Sun, Jitong
The PRECISESADS Clinical Consortium
Beretta, Lorenzo
Vigone, Barbara
Pers, Jacques-Olivier
Saraux, Alain
Devauchelle-Pensec, Valérie
Cornec, Divi
Jousse-Joulin, Sandrine
Lauwerys, Bernard
Ducreux, Julie
Maudoux, Anne-Lise
Vasconcelos, Carlos
Tavares, Ana
Neves, Esmeralda
Faria, Raquel
Source :
Scientific Reports; 7/3/2020, Vol. 10 Issue 1, p1-13, 13p
Publication Year :
2020

Abstract

IgM antibodies against phosphorylcholine (anti-PC) and malondialdehyde (anti-MDA) may have protective properties in cardiovascular and rheumatic diseases. We here compare these antibodies in systemic rheumatic conditions and study their properties. Anti-PC and anti-MDA was measured using ELISA in patients with SLE (374), RA (354), Mixed connective tissue disease (MCTD, 77), Systemic sclerosis (SSc, 331), Sjögren's syndrome (SjS, 324), primary antiphospholipid syndrome (PAPs, 65), undifferentiated connective tissue disease (UCTD, 118) and 515 matched healthy controls (HC). Cardiovascular score (CV) was broadly defined based on clinical disease symptoms. Anti-PC and anti-MDA peptide/protein characterization were compared using a proteomics de novo sequencing approach. anti-MDA and anti-PC were extracted from total IgM. The proportion of Treg cells was determined by flow cytometry. The maximal difference between cases and controls was shown for MCTD: significantly lower IgM Anti-PC but not anti-MDA among patients (median 49.3RU/ml vs 70.4 in healthy controls, p(t-test) = 0.0037). IgM low levels were more prevalent in MCTD, SLE, SjS, SSc and UCTD. IgM anti-PC variable region profiles were different from and more homologous than anti-MDA. Anti-PC but not anti-MDA were significantly negatively correlated with CV in the whole patient group. In contrast to IgM anti-PC, anti-MDA did not promote polarization of Tregs. Taken together, Anti-PC is decreased in MCTD and also in SLE, SjS and SSc but not in other studied diseases. Anti-PC may thus differentiate between these. In contrast, anti-MDA did not show these differences between diseases studied. Anti-PC level is negatively correlated with CV in the patient group cohort. In contrast to anti-PC, anti-MDA did not promote Treg polarization. These findings could have both diagnostic and therapeutic implications, one possibility being active or passive immunization with PC in some rheumatic conditions. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20452322
Volume :
10
Issue :
1
Database :
Complementary Index
Journal :
Scientific Reports
Publication Type :
Academic Journal
Accession number :
144371581
Full Text :
https://doi.org/10.1038/s41598-020-66981-z